 Quanbin Xu
Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 8 | 2016 | 630 | 1.590 |
Why?
| | Protein-Tyrosine Kinases | 8 | 2016 | 431 | 1.440 |
Why?
| | Spindle Apparatus | 4 | 2014 | 95 | 1.070 |
Why?
| | Kinetochores | 3 | 2013 | 52 | 0.740 |
Why?
| | Transforming Growth Factor alpha | 2 | 2010 | 55 | 0.630 |
Why?
| | ErbB Receptors | 2 | 2010 | 635 | 0.500 |
Why?
| | Colonic Neoplasms | 2 | 2016 | 257 | 0.460 |
Why?
| | Mitosis | 3 | 2016 | 193 | 0.450 |
Why?
| | Receptors, Cell Surface | 1 | 2016 | 372 | 0.400 |
Why?
| | Aneuploidy | 1 | 2014 | 91 | 0.400 |
Why?
| | Metaphase | 1 | 2013 | 33 | 0.390 |
Why?
| | M Phase Cell Cycle Checkpoints | 2 | 2016 | 23 | 0.370 |
Why?
| | Cell Line, Tumor | 9 | 2024 | 3542 | 0.340 |
Why?
| | Superantigens | 1 | 2010 | 70 | 0.330 |
Why?
| | Melanoma, Experimental | 1 | 2010 | 109 | 0.310 |
Why?
| | Ultraviolet Rays | 1 | 2013 | 384 | 0.310 |
Why?
| | Enterotoxins | 1 | 2010 | 89 | 0.310 |
Why?
| | Cell Division | 1 | 2011 | 756 | 0.300 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2015 | 425 | 0.300 |
Why?
| | Epidermal Growth Factor | 1 | 2010 | 162 | 0.300 |
Why?
| | Blood Pressure | 1 | 2016 | 1779 | 0.290 |
Why?
| | Cancer Vaccines | 1 | 2010 | 161 | 0.280 |
Why?
| | Signal Transduction | 7 | 2016 | 5216 | 0.280 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2011 | 456 | 0.280 |
Why?
| | Vesiculovirus | 3 | 2024 | 17 | 0.260 |
Why?
| | RNA, Small Interfering | 4 | 2020 | 637 | 0.250 |
Why?
| | Immunotherapy | 1 | 2010 | 666 | 0.230 |
Why?
| | Thiazoles | 2 | 2018 | 141 | 0.210 |
Why?
| | Carbanilides | 1 | 2024 | 3 | 0.210 |
Why?
| | Ubiquitination | 2 | 2015 | 118 | 0.200 |
Why?
| | Brain | 1 | 2016 | 2947 | 0.200 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2015 | 117 | 0.190 |
Why?
| | HEK293 Cells | 4 | 2024 | 741 | 0.190 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 219 | 0.190 |
Why?
| | Recombinant Fusion Proteins | 3 | 2010 | 666 | 0.190 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2024 | 192 | 0.180 |
Why?
| | Phosphorylation | 6 | 2014 | 1707 | 0.180 |
Why?
| | Protein Kinases | 1 | 2024 | 312 | 0.180 |
Why?
| | Down-Regulation | 2 | 2014 | 618 | 0.150 |
Why?
| | Gene Editing | 1 | 2020 | 89 | 0.150 |
Why?
| | Exosomes | 1 | 2020 | 104 | 0.150 |
Why?
| | Gene Transfer Techniques | 1 | 2020 | 187 | 0.150 |
Why?
| | Depsipeptides | 1 | 2018 | 15 | 0.140 |
Why?
| | TNF Receptor-Associated Factor 3 | 2 | 2015 | 5 | 0.140 |
Why?
| | Histone Code | 1 | 2018 | 39 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2015 | 855 | 0.130 |
Why?
| | Viral Proteins | 2 | 2024 | 350 | 0.130 |
Why?
| | Voltage-Dependent Anion Channel 1 | 2 | 2016 | 15 | 0.130 |
Why?
| | Amino Acid Sequence | 3 | 2010 | 2129 | 0.130 |
Why?
| | Enhancer Elements, Genetic | 1 | 2018 | 191 | 0.120 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2883 | 0.120 |
Why?
| | Renin | 1 | 2016 | 33 | 0.120 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2018 | 218 | 0.120 |
Why?
| | Animals | 11 | 2024 | 38030 | 0.120 |
Why?
| | Renin-Angiotensin System | 1 | 2016 | 80 | 0.110 |
Why?
| | Cell Line | 5 | 2018 | 2823 | 0.110 |
Why?
| | Angiotensin II | 1 | 2016 | 101 | 0.110 |
Why?
| | Immunity, Innate | 4 | 2014 | 835 | 0.110 |
Why?
| | Interphase | 1 | 2015 | 38 | 0.110 |
Why?
| | Karyopherins | 1 | 2015 | 20 | 0.110 |
Why?
| | Protein Binding | 3 | 2016 | 2238 | 0.110 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2015 | 96 | 0.110 |
Why?
| | Mitochondria | 2 | 2024 | 992 | 0.110 |
Why?
| | Enterovirus A, Human | 1 | 2014 | 13 | 0.100 |
Why?
| | Humans | 18 | 2024 | 145475 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 187 | 0.100 |
Why?
| | Cytoplasm | 1 | 2015 | 254 | 0.100 |
Why?
| | Oligopeptides | 1 | 2016 | 267 | 0.100 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 371 | 0.100 |
Why?
| | Mice | 8 | 2024 | 18329 | 0.100 |
Why?
| | Immune Evasion | 1 | 2014 | 61 | 0.100 |
Why?
| | DEAD-box RNA Helicases | 1 | 2014 | 83 | 0.100 |
Why?
| | Inflammasomes | 1 | 2015 | 144 | 0.100 |
Why?
| | RNA Interference | 2 | 2015 | 475 | 0.100 |
Why?
| | Protein Transport | 1 | 2015 | 442 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 207 | 0.100 |
Why?
| | Mice, Inbred C57BL | 4 | 2015 | 5983 | 0.100 |
Why?
| | Time-Lapse Imaging | 1 | 2013 | 21 | 0.100 |
Why?
| | Tamoxifen | 1 | 2014 | 191 | 0.100 |
Why?
| | Caspase 3 | 1 | 2013 | 242 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 365 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2016 | 693 | 0.090 |
Why?
| | Viral Envelope Proteins | 2 | 2024 | 98 | 0.090 |
Why?
| | Antihypertensive Agents | 1 | 2016 | 519 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 588 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 217 | 0.090 |
Why?
| | G2 Phase | 1 | 2011 | 39 | 0.090 |
Why?
| | Chromosome Segregation | 1 | 2011 | 45 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1179 | 0.080 |
Why?
| | G1 Phase | 1 | 2010 | 65 | 0.080 |
Why?
| | Quinolines | 1 | 2011 | 190 | 0.080 |
Why?
| | Vesicular stomatitis Indiana virus | 1 | 2009 | 13 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 499 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 365 | 0.070 |
Why?
| | Interferon-beta | 1 | 2009 | 92 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 886 | 0.070 |
Why?
| | Mad2 Proteins | 1 | 2008 | 5 | 0.070 |
Why?
| | Spleen | 1 | 2010 | 508 | 0.070 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2009 | 155 | 0.070 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2014 | 881 | 0.070 |
Why?
| | Immunization | 1 | 2010 | 375 | 0.070 |
Why?
| | MicroRNAs | 1 | 2014 | 686 | 0.070 |
Why?
| | Apoptosis | 2 | 2013 | 2440 | 0.070 |
Why?
| | Hypertension | 1 | 2016 | 1273 | 0.060 |
Why?
| | Calcium-Binding Proteins | 1 | 2008 | 221 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2009 | 263 | 0.060 |
Why?
| | Escherichia coli | 1 | 2010 | 835 | 0.060 |
Why?
| | Repressor Proteins | 1 | 2008 | 429 | 0.060 |
Why?
| | HeLa Cells | 2 | 2020 | 632 | 0.050 |
Why?
| | Albumins | 1 | 2024 | 119 | 0.050 |
Why?
| | Glycoproteins | 1 | 2024 | 354 | 0.040 |
Why?
| | Vesicular Stomatitis | 2 | 2013 | 3 | 0.040 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 171 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2014 | 2382 | 0.040 |
Why?
| | Caspase 9 | 1 | 2020 | 55 | 0.040 |
Why?
| | Argonaute Proteins | 1 | 2020 | 32 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 48 | 0.040 |
Why?
| | Host-Pathogen Interactions | 2 | 2014 | 361 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2024 | 381 | 0.040 |
Why?
| | Integrases | 1 | 2020 | 122 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 2 | 2014 | 321 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 407 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2010 | 762 | 0.030 |
Why?
| | Cytostatic Agents | 1 | 2018 | 6 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 138 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1261 | 0.030 |
Why?
| | Oncogenes | 1 | 2018 | 118 | 0.030 |
Why?
| | Acetylation | 1 | 2018 | 259 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2015 | 3124 | 0.030 |
Why?
| | Polyploidy | 1 | 2016 | 14 | 0.030 |
Why?
| | Histone Deacetylases | 1 | 2018 | 207 | 0.030 |
Why?
| | Cytokinesis | 1 | 2016 | 50 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2024 | 3413 | 0.030 |
Why?
| | Genome | 1 | 2018 | 305 | 0.030 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 148 | 0.030 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| | Polyubiquitin | 1 | 2014 | 8 | 0.030 |
Why?
| | DEAD Box Protein 58 | 1 | 2014 | 7 | 0.030 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2014 | 17 | 0.030 |
Why?
| | Immunoblotting | 1 | 2015 | 295 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 382 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2018 | 350 | 0.030 |
Why?
| | Vero Cells | 1 | 2014 | 83 | 0.030 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 78 | 0.030 |
Why?
| | Phosphoserine | 1 | 2014 | 25 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2014 | 64 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2028 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2015 | 408 | 0.020 |
Why?
| | Interferon Type I | 1 | 2014 | 147 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1246 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2013 | 51 | 0.020 |
Why?
| | Receptors, Immunologic | 1 | 2014 | 208 | 0.020 |
Why?
| | Cell Survival | 1 | 2016 | 1100 | 0.020 |
Why?
| | Dogs | 1 | 2014 | 458 | 0.020 |
Why?
| | TNF Receptor-Associated Factor 6 | 1 | 2012 | 6 | 0.020 |
Why?
| | Protein Stability | 1 | 2013 | 176 | 0.020 |
Why?
| | Virus Diseases | 1 | 2015 | 216 | 0.020 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 151 | 0.020 |
Why?
| | Histones | 1 | 2018 | 666 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 204 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1896 | 0.020 |
Why?
| | Virus Replication | 1 | 2014 | 521 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 969 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 847 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2803 | 0.020 |
Why?
| | Catalysis | 1 | 2010 | 305 | 0.020 |
Why?
| | Mutation | 2 | 2010 | 4075 | 0.020 |
Why?
| | Protein Subunits | 1 | 2009 | 229 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2009 | 387 | 0.020 |
Why?
| | Fibroblasts | 1 | 2013 | 1025 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1454 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1368 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1507 | 0.020 |
Why?
| | Protein Conformation | 1 | 2009 | 938 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2597 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1598 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2009 | 1164 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4148 | 0.010 |
Why?
| | Female | 2 | 2020 | 78845 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 11772 | 0.010 |
Why?
|
|
Xu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|